Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Yasunori Minami"'
Autor:
Satoru Hagiwara, Kosuke Minaga, Masatomo Kimura, Kazuomi Ueshima, Tomoko Aoki, Hidetoshi Hayashi, Yasunori Minami, Yoriaki Komeda, Hirokazu Cishina, Naoshi Nishida, Ken Kamata, Ah-Mee Park, Masahiro Morita, Masatoshi Kudo, Masahiro Takita, Hiroshi Ida, Kazuhiko Nakagawa, Tomohiro Watanabe
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Immune checkpoint inhibitors (ICIs) targeting programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) are widely used to treat advanced metastatic cancers. Neutralisation of PD-1 or CTLA-4 by ICIs results in immune-related advers
Autor:
Kazuomi Ueshima, Yoriaki Komeda, Hiroshi Ida, Naoshi Nishida, Masatoshi Kudo, Satoru Hagiwara, Yasunori Minami, Masahiro Takita
Publikováno v:
Journal of Medical Virology. 91:1804-1810
Tenofovir alafenamide (TAF) is a newly developed prodrug of tenofovir (TFV). We divided 48 chronic hepatitis B patients who had taken entecavir (ETV) for ≥2 years into two groups: the ETV continuation (n = 24) and the TAF switching (n = 24) groups,
Autor:
Hiroshi Ida, Takamichi Murakami, Masatoshi Kudo, Satoru Hagiwara, Yasunori Minami, Tomohiro Minami, Kazuomi Ueshima, Naoshi Nishida
Publikováno v:
European Radiology. 28:1986-1993
To assess the clinical feasibility of US-US image overlay fusion with evaluation of the ablative margin in radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Fifty-three patients with 68 HCCs measuring 0.9–4.0 cm who underwent RFA gu
Autor:
Naoshi Nishida, Kazuomi Ueshima, Hiroshi Ida, Hirokazu Chishina, Satoru Hagiwara, Masatoshi Kudo, Yoriaki Komeda, Toshiharu Sakurai, Yasuko Umehara, Masahiro Takita, Yasunori Minami, Tadaaki Arizumi, Tomohiro Watanabe, Tomohiro Minami
Publikováno v:
Digestive Diseases. 35:548-555
Objective: It is a generally accepted fact that eradication of hepatitis virus C inhibits the subsequent development of hepatocellular carcinoma (HCC). On the contrary, a significant population of patients developed HCC despite sustained virological
Autor:
Masashi Kono, Hiroshi Ida, Tadaaki Arizumi, Tomohiro Minami, Hirokazu Chishina, Satoru Hagiwara, Masahiro Takita, Norihisa Yada, Kazuomi Ueshima, Naoshi Nishida, Yasunori Minami, Masatoshi Kudo
Publikováno v:
Digestive Diseases. 35:565-573
Background: Interferon-based antiviral therapies against hepatitis C virus (HCV) infection have been shown to reduce the incidence of hepatocellular carcinoma (HCC) in patients with sustained viral response (SVR). Recently, direct-acting antivirals (
Autor:
Kazuomi Ueshima, Ken Kamata, Hiroshi Ida, Mamoru Takenaka, Yoriaki Komeda, Toshiharu Sakurai, Hirokazu Chishina, Tomohiro Minami, Masahiro Takita, Tadaaki Arizumi, Tomohiro Watanabe, Masashi Kono, Masatoshi Kudo, Naoshi Nishida, Satoru Hagiwara, Kosuke Minaga, Yasunori Minami, Norihisa Yada
Publikováno v:
Digestive Diseases. 35:556-564
Background and Aims: Direct-acting antivirals (DAAs) dramatically improve the sustained virological response (SVR) of chronic hepatitis C (CHC) patients. However, continuous liver damage after SVR may be a risk of hepatocellular carcinoma (HCC). We c
Autor:
Hirohito Yoneyama, Yasunori Minami, Joji Tani, Atsushi Kubo, Kazuomi Ueshima, Chikara Ogawa, Akio Moriya, Masaharu Ando, Akihiro Deguchi, Kouichi Takaguchi, Naoshi Nishida, Toshihiro Matsunaka, Mitsushige Shibatoge, Asahiro Morishita, Akemi Tsutsui, Toshiharu Sakurai, Hiroyuki Tamaki, Akina Omura, Teruyo Noda, Tsutomu Masaki, Masahiro Morita, Yasutaka Kokudo, Masatoshi Kudo, Takuya Nagano, Tomonori Senoh
Publikováno v:
Oncology. 93:113-119
Objective: To determine the relationship between treatment outcomes and hand-foot syndrome (HFS), and the relationship between survival rate and post-progression treatment after sorafenib therapy. Methods: The study assessed 314 patients with advance
Autor:
Tsutomu Kumabe, Osamu Nakashima, Takuya Nakai, Fukuo Kondo, Masatoshi Kudo, Toshiharu Sakurai, Tadaaki Arizumi, Tomohiro Watanabe, Mina Iwanishi, Yasunori Minami, Kazuomi Ueshima, Satoru Hagiwara, Tomohiro Minami, Yoriaki Komeda, Eisuke Enoki, Wing Yee Kwok, Masahiro Takita, Masashi Kono, Hiroshi Ida, Naoshi Nishida, Hirokazu Chishina
Publikováno v:
Oncology. 92:16-28
The patient was a 20-year-old male in whom a hepatic hypervascular mass accompanied by intratumoral hemorrhage was detected on examination for epigastric pain. Based on the enlargement of the mass and diagnostic imaging, hepatocellular adenoma (HCA)
Autor:
Yoriaki Komeda, Satoru Hagiwara, Hiroshi Ida, Masatoshi Kudo, Mina Iwanishi, Masahiro Takita, Toshiharu Sakurai, Tadaaki Arizumi, Yasunori Minami, Naoshi Nishida, Norihisa Yada, Tomohiro Minami, Hirokazu Chishina, Masashi Kono, Kazuomi Ueshima
Publikováno v:
Oncology. 92:29-34
Objective: To compare contrast tissue harmonic imaging (THI) with low mechanical index (MI) and conventional contrast harmonic imaging (CHI) with respect to lesion visibility of hepatocellular carcinoma (HCC). Methods: One hundred and twenty-five pat
Autor:
Keiichi Aomatsu, Tokuzo Arao, Tomoyuki Nagai, Toshiharu Sakurai, Nagahiro Saijo, Kazuto Nishio, Hideharu Kimura, Satoru Hagiwara, Seiji Haji, Kazuomi Ueshima, Kazuko Sakai, Hiroyasu Kaneda, Kanae Kudo, Masatoshi Kudo, Naoshi Nishida, Kazuko Matsumoto, Hiroshi Ida, Yasunori Minami, Yoshihiko Fujita, Daisuke Tamura
Publikováno v:
Digestive Diseases. 34:702-707
Background: Epithelial-mesenchymal transition (EMT) is considered to play a critical role in cancer progression and metastasis. However, the impact of EMT on the prognosis of hepatocellular carcinoma (HCC) is still elusive. In this study, we examined